Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.
about
Targeting BMP signalling in cardiovascular disease and anaemiaActivin receptor-like kinases: a diverse family playing an important role in cancerRegulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.Bone Morphogenetic Protein (BMP) signaling in development and human diseasesBMP-9 balances endothelial cell fate.Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosisDual targeting of vascular endothelial growth factor and bone morphogenetic protein-9/10 impairs tumor growth through inhibition of angiogenesis.Alk3/Alk3b and Smad5 mediate BMP signaling during lymphatic development in zebrafish.Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.BMP signaling and its paradoxical effects in tumorigenesis and dissemination.VEGF, Notch and TGFβ/BMPs in regulation of sprouting angiogenesis and vascular patterning.Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis.Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses.Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.Executive summary of the 11th HHT international scientific conference.Transplantation of artificial human lymphatic vascular tissues fabricated using a cell-accumulation technique and their engraftment in mouse tissue with vascular remodelling.ALK1 signaling in development and disease: new paradigms.RV pressure overload: from hypertrophy to failure.Bone Morphogenetic Proteins.Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
P2860
Q26783734-4594017E-73D5-4AE2-AAB4-A9E0341FFC6BQ28066886-8AB5FDEA-61B2-4338-B71F-22EDC81673D0Q34467523-B1D22BE8-ADB8-449C-8ECB-4B92AC866E72Q34512444-8F9E7FF0-2BAB-44B1-9C6E-8D4396034B91Q37340878-F8A48D13-CA82-4DDC-A394-974F6E354CA8Q37555371-97684548-A2C6-4E16-92F4-79D35F2C7FA9Q37611674-87C52184-A82E-4DC4-8512-E9171A1733FEQ37671260-FA79F223-008F-4C36-BB73-1C5C8EFF709CQ37687466-4457F37F-4AE0-4519-9B16-40B40F8E64FDQ37718513-FF6490BE-14FA-4CAD-841B-563648098192Q38268447-384E3D7C-A5C0-485F-9CE3-B935F8142281Q38332401-06350A85-DCB0-4922-813C-BDD73EBB9A0FQ38979355-E4A8EE6D-F027-4617-9914-5BAE1E7E1C42Q39063008-E20BB0B7-75B8-487E-9DB0-8A8D86079BC7Q39676371-5F1BDB66-C6F2-43E6-8364-4192B98B8EE9Q41484602-965C2737-6C20-4D4F-A18F-946C64126D54Q41900072-8EC66FF7-BCFA-4942-B62D-74E144C067F1Q44800182-39C40BB7-EA9D-4EF2-95DC-82F2D1FD2591Q47712123-1B958ACE-6957-43CD-8446-188CD1C33169Q47856805-4BFADEFC-6208-4F4D-8EAE-509615E58208Q49679389-E2608896-5E98-414A-B3F5-8E8EE9AE950BQ51724862-929AA6A4-F594-4887-8976-979E27AB0C11Q52595509-8390B6EC-ED1E-4469-8D47-423771ECBBF8
P2860
Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bone morphogenetic protein-9 i ...... opment and cancer progression.
@en
Bone morphogenetic protein-9 i ...... opment and cancer progression.
@nl
type
label
Bone morphogenetic protein-9 i ...... opment and cancer progression.
@en
Bone morphogenetic protein-9 i ...... opment and cancer progression.
@nl
prefLabel
Bone morphogenetic protein-9 i ...... opment and cancer progression.
@en
Bone morphogenetic protein-9 i ...... opment and cancer progression.
@nl
P2093
P2860
P50
P356
P1476
Bone morphogenetic protein-9 i ...... lopment and cancer progression
@en
P2093
Akihiro Katsura
Gou Young Koh
Hiroshi I Suzuki
Kohei Miyazono
Luna Taguchi
Sara I Cunha
Se-Jin Lee
Tetsuro Watabe
Tomoko Yamazaki
P2860
P304
18940-18945
P356
10.1073/PNAS.1310479110
P407
P577
2013-10-16T00:00:00Z